In the modern medical era, the gut microbiome is often referred to as the "second brain." The global market for stool analysis kits has transitioned from basic parasitic detection to advanced molecular diagnostics, including colorectal cancer screening, inflammatory bowel disease (IBD) monitoring, and metabolic health assessment. Manufacturers and suppliers are now integrating AI-driven analysis with non-invasive collection methods to improve patient compliance and diagnostic accuracy.
A global giant providing comprehensive digestive health panels with high-throughput laboratory systems.
Pioneers of the Cologuard test, leading the way in DNA-based non-invasive screening.
Integrating stool chemistry with automated clinical lab workflows for maximum efficiency.
Leading the shift toward smart wearable integration and high-capacity diagnostic kit manufacturing.
Excellence in fecal immunochemical testing (FIT) with precision Japanese engineering.
Providing robust chemical and biochemical analysis platforms for global hospital networks.
Focused on specialized assays for detecting enteric pathogens and specialized gut flora.
The gold standard for DNA/RNA extraction from stool samples for microbiome research.
Specializing in rapid immunoassay tests for parasitic and bacterial infections.
Leading supplier in Europe for automated fecal sample processing and digital pathology.
Met Health
